Skip to content

For European medical media: CLL10 Suggests Levact & Rituximab as New Treatment Option for Fit Elderly CLL Patients

Release Date: 09 Dec 2013
New interim analysis study findings presented for the first time at the 55th American Society of Hematology (ASH) Annual Meeting in New Orleans suggest bendamustine and rituximab (BR) as a new treatment option for fit elderly patients with advanced Chronic Lymphocytic Leukaemia (CLL)
adding all to cart
False 0
File added to media cart.